Cruzain: Difference between revisions

From Proteopedia
Jump to navigationJump to search
Michal Harel (talk | contribs)
No edit summary
Michal Harel (talk | contribs)
No edit summary
Line 6: Line 6:


Cru inhibitors are being investigated for therapeutic use against Chagas disease.
Cru inhibitors are being investigated for therapeutic use against Chagas disease.
== Structural highlights ==
Cru catalytic triad is Cys-His-Asn.


</StructureSection>
</StructureSection>

Revision as of 11:30, 15 December 2015

Structure of cruzain catalytic domain complex with methylketone inhibitor (PDB entry 1me3)

Drag the structure with the mouse to rotate

3D structures of cruzain

Updated on 15-December-2015

1aim, 2aim, 1me3, 1me4 – Cru catalytic domain + methylketone inhibitor – Trypanosoma cruzi
1f29, 1f2a, 1f2b, 1f2c, 1ewo, 3lxs - Cru catalytic domain + vinyl sulfone derived inhibitor
1ewl, 1ewm – Cru catalytic domain + methylbutane inhibitor
1ewp - Cru catalytic domain + MOR-Leu-HPQ

References

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky